Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Rockwell Poised For Post-Offering Bounce Ahead Of Phase III Results
Seeking Alpha
Saturday, March 23, 2013 - 9:52am
tags:
Rockwell Medical, Soluble Ferric Pyrophosphate, renal disease
Will This Treatment Help Anacor’s Stock Soar?
Wall Street Cheat Street
Saturday, March 23, 2013 - 9:50am
tags:
Anacor, AN2728, eczema
Reasons To Consider Eli Lilly Over Other Pharmaceutical Giants
Seeking Alpha
Saturday, March 23, 2013 - 9:49am
tags:
Eli Lilly
U.K. Regulators Sour on Novartis Breast Cancer Drug Afinitor
Motley Fool
Saturday, March 23, 2013 - 9:48am
tags:
Novartis, Afinitor, breast cancer
Circassia to Sell Own Cat-Allergy Vaccine If Test Works
Bloomberg
Saturday, March 23, 2013 - 9:47am
tags:
Circassia, vaccines, allergies
AstraZeneca/Moderna Ink Deal
Yahoo/Zacks
Saturday, March 23, 2013 - 9:45am
tags:
AstraZeneca, Moderna
Europe and US Diverge On Two New Drugs
Forbes
Saturday, March 23, 2013 - 9:41am
tags:
Xarelto, mipomersen, JNJ, Genzyme
Why Titan Pharmaceuticals Is Currently Undervalued
Seeking Alpha
Saturday, March 23, 2013 - 9:03am
tags:
Titan Pharmaceuticals
6 Reasons To Buy Arena Pharmaceuticals Right Now
Seeking Alpha
Saturday, March 23, 2013 - 9:03am
tags:
Arena Pharmaceutical
Law Office of Brodsky & Smith, LLC Announces Investigation of Obagi Medical Products, Inc.
Yahoo/PR Newswire
Saturday, March 23, 2013 - 9:01am
tags:
Obagi Medical Products, lawsuits
2 Cancer Biotechs With Upcoming FDA Approval Decisions In 2013
Seeking Alpha
Saturday, March 23, 2013 - 9:00am
tags:
Delcath, Aveo Pharmaceutical, tivozanib, renal cell carcinoma, Chemosat, melanoma, metastatic melanoma
Why Celgene's Management Is a Strength
Motley Fool
Saturday, March 23, 2013 - 8:58am
tags:
Celgene
GenVec Q4 Net Loss Deepens
Motley Fool
Saturday, March 23, 2013 - 8:56am
tags:
GenVec, earnings
Ariad's Potential Blockbuster Set for EU Debut
Motley Fool
Saturday, March 23, 2013 - 8:54am
tags:
Ariad, Iclusig, chronic myeloid leukemia
Idenix Pharmaceuticals Announces Decision by the United States Patent and Trademark Office Patent Trial and Appeal Board
Yahoo/GlobeNewsWire
Saturday, March 23, 2013 - 8:52am
tags:
Gilead Pharmasset, Idenix, hepatitis C, patents
Titan Shares Rise After FDA Panel Backs Opioid Implant
Bloomberg
Saturday, March 23, 2013 - 8:49am
tags:
Titan Pharmaceuticals, Probuphine, opioid addiction
Biogen, Baxter, Sanofi, Gilead Win EU Endorsements
Investors.com
Friday, March 22, 2013 - 11:45am
tags:
Biogen Idec, Baxter International, Sanofi, Gilead, Europe, BG-12, Tecfidera, Aubagio, HyQvia, Halozyme, Stribild
Discovery Laboratories: The Surfaxin Launch And Beyond
Seeking Alpha
Friday, March 22, 2013 - 11:37am
tags:
Surfaxin, Discovery Labs
Medical device maker Cytori loses approval fight
Reuters
Friday, March 22, 2013 - 11:30am
tags:
Cytori, stem cells, devices
EMA rejects Genzyme re-examination request for Kynamro
Yahoo/Fly on the Wall
Friday, March 22, 2013 - 11:29am
tags:
Europe, Genzyme, Kynamro, Sanofi, hypercholesterolemia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.